Cited by 596Bone health and osteoporosis researchBone health and treatmentsBone Metabolism and Diseases

The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.

Use of bone turnover markers in postmenopausal osteoporosis

Eastell, Richard, Szulc, Pawel·2017·The Lancet Diabetes & Endocrinology

Open this paper in CoChat — free account

Abstract

Bone turnover comprises two processes: the removal of old bone (resorption) and the laying down of new bone (formation). N-terminal propeptide of type I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of bone formation and resorption, respectively, that are recommended for clinical use. Bone turnover markers can be measured on several occasions in one individual with good precision. However, these markers are subject to several sources of variability, including feeding (resorption decreases) and recent fracture (all markers increase for several months). Bone turnover markers are not used for diagnosis of osteoporosis and do not improve prediction of bone loss or fracture within an individual. In untreated women, very high bone turnover marker concentrations suggest secondary causes of high bone turnover (eg, bone metastases or multiple myeloma). In people with osteoporosis, bone turnover markers might be useful to assess the response to anabolic and antiresorptive therapies, to assess compliance to therapy, or to indicate possible secondary osteoporosis. Much remains to be learnt about how bone turnover markers can be used to monitor the effect of stopping bisphosphonate therapy (eg, to identify a threshold above which restarting therapy should be considered). More studies are needed to investigate the use of bone turnover markers for assessment of the bone safety of new medications.

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(17)30184-5

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Khan, A. A., Morrison, A. D., Hanley, D. A., Felsenberg, D., McCauley, L. K., O’Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,360
Self-citation
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Self-citation
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedűs, L. D., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,087
Molecular Mechanisms Mediating Proliferation/Differentiation Interrelationships During Progressive Development of the Osteoblast Phenotype
Stein, G. S., & Lian, J. B. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-424 · Cited by 1,058

Show all 168 references

Sorted by citations

Bone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaça, T., Gossiel, F., Salam, S., & Eastell, R. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 439
Self-citation
Biomarkers of aging
Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 402
Osteogenesis and aging: lessons from mesenchymal stem cells
Infante, A., & Rodríguez, C. I. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0995-x · Cited by 334
Guidelines for the management of osteoporosis and fragility fractures
Nuti, R., Brandi, M. L., Checchia, G., Di Munno, O., Dominguez, L., Falaschi, P., Fiore, C. E., Iolascon, G., Maggi, S., Michieli, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1874-2 · Cited by 328
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure
Guo, M., Liu, H., Yu, Y., Zhu, X., Xie, H., Wei, C., Mei, C., Shi, Y. W., Zhou, N., Qin, K., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2190304 · Cited by 296
Long-term and sequential treatment for osteoporosis
Foessl, I., Dimai, H. P., & Obermayer-Pietsch, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00866-9 · Cited by 273
Chitosan and gelatin-based electrospun fibers for bone tissue engineering
Sruthi, R., Balagangadharan, K., & Selvamurugan, N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.04.115 · Cited by 236
Fragility Fractures: Risk Factors and Management in the Elderly
Migliorini, F., Giorgino, R., Hildebrand, F., Spiezia, F., Peretti, G. M., Bonetti, M. A., Eschweiler, J., & Maffulli, N. (2021) · Medicina · doi:10.3390/medicina57101119 · Cited by 243
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
Asadipooya, K., & Uy, E. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00160 · Cited by 210
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
Evenepoel, P., Cunningham, J., Ferrari, S., Haarhaus, M. L., Javaid, M. K., Lafage‐Proust, M., Prieto‐Alhambra, D., Ureña, P., Cannata-Andía, J. B., Vervloet, M. G., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa192 · Cited by 226
Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
Guo, J., Wang, F., Hu, Y., Luo, Y., Wei, Y., Xu, K., Zhang, H., Liu, H., Bo, L., Lv, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100881 · Cited by 126
Osteoporosis and Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Back to Basics
Pazianas, M., & Miller, P. D. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.12.024 · Cited by 164
The importance of the circadian system & sleep for bone health
Swanson, C. M., Kohrt, W. M., Buxton, O. M., Everson, C. A., Wright, K. P., ORWOLL, E. S., & Shea, S. A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.002 · Cited by 161
Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review
Migliorini, F., Maffulli, N., Spiezia, F., Tingart, M., Maria, P. G., & Giorgino, R. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02474-7 · Cited by 151
Bone turnover: Biology and assessment tools
Szulc, P. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.003 · Cited by 140
Self-citation
Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review
Migliorini, F., Maffulli, N., Spiezia, F., Peretti, G. M., Tingart, M., & Giorgino, R. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02497-0 · Cited by 138
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Bhattoa, H. P., Vasikaran, S. D., Trifonidi, I., Kapoula, G., Lombardi, G., Jørgensen, N. R., Pikner, R., Miura, M., Chapurlat, R. D., Hiligsmann, M., et al. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07422-3 · Cited by 148
Bone alkaline phosphatase: An important biomarker in chronic kidney disease – mineral and bone disorder
Nizet, A., Cavalier, E., Stenvinkel, P., Haarhaus, M. L., & Magnusson, P. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.012 · Cited by 119
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
Lorentzon, M., Branco, J., Brandi, M. L., Bruyère, O., Chapurlat, R. D., Cooper, C. C., Cortet, B., Díez‐Pérez, A., Ferrari, S., Gáspárik, A. I., et al. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01063-9 · Cited by 121
Self-citation
Systemic immune‐inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture
Fang, H., Zhang, H., Wang, Z., Zhou, Z., Li, Y., & Lü, L. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23016 · Cited by 113
Iron Deficiency and Iron Deficiency Anemia: Potential Risk Factors in Bone Loss
Yang, J., Li, Q., Feng, Y., & Zeng, Y. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086891 · Cited by 142
Bone targeting antioxidative nano-iron oxide for treating postmenopausal osteoporosis
Zheng, L., Zhuang, Z., Li, Y., Shi, T., Fu, K., Yan, W., Zhang, L., Wang, P., Li, L., & Jiang, Q. Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.012 · Cited by 112
Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model
Liu, H., Xiong, Y., Wang, H., Yang, L., Wang, C., Liu, X., Wu, Z., Li, X., Ou, L., Zhang, R., et al. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.04.035 · Cited by 101
Molecular Classification of Knee Osteoarthritis
Lv, Z., Yang, Y., Li, J.-W., Fei, Y.-X., Guo, H., Sun, Z.-Y., Lu, J., Xu, X.-Q., Jiang, Q., Ikegawa, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725568 · Cited by 93
Ferroptosis - A new target of osteoporosis
Gao, Z., Chen, Z., Xiong, Z., & Liu, X. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111836 · Cited by 89
Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1
Huang, C., & Wang, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05362-y · Cited by 82
Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix
Kehlet, S. N., Willumsen, N., Armbrecht, G., Dietzel, R., Brix, S., Henriksen, K., & Karsdal, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194458 · Cited by 81
Functional Calcium Binding Peptides from Pacific Cod (Gadus macrocephalus) Bone: Calcium Bioavailability Enhancing Activity and Anti-Osteoporosis Effects in the Ovariectomy-Induced Osteoporosis Rat Model
Zhang, K., Li, B., Chen, Q., Zhang, Z., Zhao, X., & Hou, H. (2018) · Nutrients · doi:10.3390/nu10091325 · Cited by 79
Circulating miR-181c-5p and miR-497-5p Are Potential Biomarkers for Prognosis and Diagnosis of Osteoporosis
Ma, J., Lin, X., Chen, C., Li, S., Zhang, S., Chen, Z., Li, D., Zhao, F., Yang, C., Yin, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz300 · Cited by 83
Global epidemiology and burden of osteoporosis among postmenopausal women: insights from the Global Burden of Disease Study 2021
Liang, H., Chen, S., Shi, M., Xu, J., Zhao, C., Yang, B., Zheng, S., & Tan, J. (2025) · npj Aging · doi:10.1038/s41514-025-00269-2 · Cited by 76
Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
Mederle, O. A., Balaş, M., Ioanoviciu, S. D., Gurban, C., Tudor, A., & Borza, C. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s170111 · Cited by 75
Clinical immunity in bone and joints
Tanaka, Y. (2018) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-018-0965-5 · Cited by 74
The effect of exercise intensity on bone in postmenopausal women (part 1): A systematic review
Kistler-Fischbacher, M., Weeks, B. K., & Beck, B. R. (2020) · Bone · doi:10.1016/j.bone.2020.115696 · Cited by 76
Soy isoflavones prevent bone resorption and loss, a systematic review and meta-analysis of randomized controlled trials
Akhlaghi, M., Ghaseminasab-Parizi, M., Riasatian, M., & Sadeghi, F. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1635078 · Cited by 72
The potential mechanism of the microbiota-gut-bone axis in osteoporosis: a review
He, Y., & Chen, Y. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06557-x · Cited by 75
18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications
Park, P. S. U., Raynor, W., Sun, Y. Y., Werner, T. J., Rajapakse, C. S., & Alavi, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126504 · Cited by 72
Risk Factors for New Vertebral Fracture After Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures
Zhang, Z., Yang, J.-S., Hao, D., Liu, T.-J., & Jing, Q. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s312623 · Cited by 70
Use of bone turnover markers in the management of osteoporosis
Jain, S., & Camacho, P. M. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000446 · Cited by 65
Evaluating the Activity of Sodium Butyrate to Prevent Osteoporosis in Rats by Promoting Osteal GSK-3β/Nrf2 Signaling and Mitochondrial Function
Xue Ming, T. A. N. G., Ma, S., Li, Y., Sun, Y., Zhang, K., Zhou, Q., & Yu, R. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01820 · Cited by 63
A Mini Review on Osteoporosis: From Biology to Pharmacological Management of Bone Loss
Chin, K., Ng, B. N., Rostam, M. K. I., Fadzil, N. F. D. M., Raman, V., Yunus, F. M., Hashim, S. A. S., & Ekeuku, S. O. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216434 · Cited by 67
Brain to bone: What is the contribution of the brain to skeletal homeostasis?
Idelevich, A., & Baron, R. (2018) · Bone · doi:10.1016/j.bone.2018.05.018 · Cited by 62
Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
He, T., Qin, L., Chen, S., Huo, S., Li, J., Zhang, F., Yi, W., Mei, Y., & Xiao, G. (2025) · Bone Research · doi:10.1038/s41413-025-00424-1 · Cited by 58
PSMC6 promotes osteoblast apoptosis through inhibiting PI3K/AKT signaling pathway activation in ovariectomy‐induced osteoporosis mouse model
Zhang, Y., Cao, X., Li, P., Fan, Y., Zhang, L., Li, W., & Liu, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29261 · Cited by 58
M1 macrophage‐derived exosomes aggravate bone loss in postmenopausal osteoporosis via a microRNA‐98/DUSP1/JNK axis
Yu, L., Hu, M. C., Cui, X., Bao, D., Luo, Z., Li, D., Li, L., Liu, N., Wu, Y., Luo, X., et al. (2021) · Cell Biology International · doi:10.1002/cbin.11690 · Cited by 56
Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
Nagy, E. E., Nagy-Finna, C., Popoviciu, H. V., & Kovács, B. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s242288 · Cited by 57
How zoledronic acid improves osteoporosis by acting on osteoclasts
Wang, B., Zhan, Y., Yan, L. W., & Hao, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.961941 · Cited by 52
Association between the metabolome and bone mineral density in a Chinese population
Mei, Z., Dong, X. W., Qian, Y., Hong, D., Xie, Z., Yao, G., Qin, A., Gao, S., Hu, J., Liang, L., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103111 · Cited by 52
Application of machine learning model to predict osteoporosis based on abdominal computed tomography images of the psoas muscle: a retrospective study
Huang, C., Hu, J.-S., Tan, K., Zhang, W., Xu, T.-H., & Yang, L. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03502-9 · Cited by 52
Soy Isoflavones and Bone Health: Focus on the RANKL/RANK/OPG Pathway
Hooshiar, S. H., Tobeiha, M., & Jafarnejad, S. (2022) · BioMed Research International · doi:10.1155/2022/8862278 · Cited by 48
Biochemical Markers of Bone Fragility in Patients With Diabetes
Meier, C., Eastell, R., Pierroz, D. D., Lane, N. E., Al‐Daghri, N. M., Suzuki, A., Napoli, N., Mithal, A., Chakhtoura, M., Fuleihan, G. E., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad255 · Cited by 53
Self-citation
Diagnostic Approach to Abnormal Alkaline Phosphatase Value
Minisola, S., Cipriani, C., Colangelo, L., Labbadia, G., Pepe, J., & Magnusson, P. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.11.019 · Cited by 52
GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment
Gabe, M. B. N., Skov‐Jeppesen, K., Gasbjerg, L. S., Schiellerup, S. P., Martinussen, C., Gadgaard, S., Boer, G. A., Oeke, J., Torz, L., Veedfald, S., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106058 · Cited by 47
Extracellular vesicles from bone marrow mesenchymal stem cells alleviate osteoporosis in mice through USP7-mediated YAP1 protein stability and the Wnt/β-catenin pathway
Wang, X., Zou, C., Hou, C., Bian, Z., Jiang, W., Li, M., & Zhu, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115829 · Cited by 46
East meets West: current practices and policies in the management of musculoskeletal aging
Xia, W., Cooper, C. C., Li, M., Xu, L., Rizzoli, R., Zhu, M. J., Lin, H. V., Beard, J., Ding, Y., Yu, W., et al. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01282-8 · Cited by 46
Folic Acid Attenuates High-Fat Diet-Induced Osteoporosis Through the AMPK Signaling Pathway
He, H., Zhang, Y., Sun, Y., Zhang, Y., Xu, J., Yang, Y., & Chen, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.791880 · Cited by 44
Polyphenols as potential preventers of osteoporosis: A comprehensive review on antioxidant and anti-inflammatory effects, molecular mechanisms, and signal pathways in bone metabolism
Su, Z., Yao, B., Liu, G., & Fang, J. Q. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109488 · Cited by 49
Circular RNA hsa_circ_0076690 acts as a prognostic biomarker in osteoporosis and regulates osteogenic differentiation of hBMSCs via sponging miR-152
Han, S., Kuang, M., Sun, C., Wang, H., Wang, D., & Liu, Q. (2020) · Aging · doi:10.18632/aging.103560 · Cited by 42
Genistein Improves Bone Healing via Triggering Estrogen Receptor Alpha-Mediated Expressions of Osteogenesis-Associated Genes and Consequent Maturation of Osteoblasts
Wu, G., Chen, J., Cherng, Y., Chang, C., Liu, S., & Chen, R. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c02830 · Cited by 42
The Non-invasive Diagnosis of Bone Disorders in CKD
Bover, J., Ureña, P., Cozzolino, M. G., Rodríguez-García, M., & Gómez‐Alonso, C. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00781-5 · Cited by 39
Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial
Vallibhakara, S. A.-O., Nakpalat, K., Sophonsritsuk, A., Tantitham, C., & Vallibhakara, O. (2021) · Nutrients · doi:10.3390/nu13124226 · Cited by 39
Bone Turnover Status: Classification Model and Clinical Implications
Fisher, A., Fisher, L., Srikusalanukul, W., & Smith, P. N. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.22747 · Cited by 38
Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
Ueland, T., Stilgren, L. S., & Bollerslev, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122896 · Cited by 39
Differences in subchondral trabecular bone microstructure and finite element analysis-based biomechanical properties between osteoporosis and osteoarthritis
He, Z., Chu, L., Liu, X., Han, X., Zhang, K., Yan, M., Li, X., & Yu, Z. (2020) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2020.05.006 · Cited by 37
Young osteocyte-derived extracellular vesicles facilitate osteogenesis by transferring tropomyosin-1
Wang, Z., Lin, X., Cao, J., Liu, Y.-W., Luo, Z.-W., Rao, S.-S., Wang, Y., Wang, Y.-Y., Chen, C., Zhu, G., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02367-x · Cited by 42
Noncoding RNA miR‐205‐5p mediates osteoporosis pathogenesis and osteoblast differentiation by regulating RUNX2
Huang, M., Li, X., Zhou, C., Si, M., Zheng, H., Chen, L., & Ding, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29599 · Cited by 35
Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study
Qu, X., Zheng, B., Chen, T., Cao, Z., Qu, B., & Jiang, T. (2019) · Orthopaedic Surgery · doi:10.1111/os.12596 · Cited by 33
Remote-controllable bone-targeted delivery of estradiol for the treatment of ovariectomy-induced osteoporosis in rats
Guo, Y., Liu, Y., Shi, C., Wu, T., Cui, Y., Wang, S., Liu, P., Feng, X., He, Y., & Fu, D. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00976-4 · Cited by 35
Sclerostin: From Molecule to Clinical Biomarker
Omran, A. S., Atanasova, D., Landgren, F., & Magnusson, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094751 · Cited by 44
Er-Xian decoction attenuates ovariectomy-induced osteoporosis by modulating fatty acid metabolism and IGF1/PI3K/AKT signaling pathway
Ma, Y., Hu, J., Song, C., Li, P., Cheng, Y., Wang, Y., Liu, H., Chen, Y., & Zhang, Z. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115835 · Cited by 34
Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity
Cao, G., Hu, S., Ning, Y., Dou, X., Ding, C., Wang, L., Wang, Z., Sang, X., Yang, Q., Shi, J., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1370900 · Cited by 34
RETRACTED: Effect of resveratrol and mesenchymal stem cell monotherapy and combined treatment in management of osteoporosis in ovariectomized rats: Role of SIRT1/FOXO3a and Wnt/β-catenin pathways
Elseweidy, M. M., El-Swefy, S. E., Shaheen, M. A., Baraka, N. M., & Hammad, S. K. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108856 · Cited by 34
Retracted
The Effects of Milk Supplementation on Bone Health Indices in Adults: A Meta-Analysis of Randomized Controlled Trials
Hidayat, K., Chen, J., Wang, T., Liu, Y., Shi, Y., Su, H.-W., Liu, B., & Qin, L. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab136 · Cited by 33
Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index
Han, H., Li, R., Fu, D., Zhou, H., Zhan, Z., Wu, Y., & Meng, B. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07284-6 · Cited by 35
Photobiomodulation: An Effective Approach to Enhance Proliferation and Differentiation of Adipose-Derived Stem Cells into Osteoblasts
Silva, D. D., Crous, A., & Abrahamse, H. (2021) · Stem Cells International · doi:10.1155/2021/8843179 · Cited by 32
Chronobiology and Chronotherapy of Osteoporosis
Winter, E. M., Kooijman, S., Appelman‐Dijkstra, N. M., Meijer, O. C., Rensen, P. C. N., & Schilperoort, M. (2021) · JBMR Plus · doi:10.1002/jbm4.10504 · Cited by 33
Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women
Du, Y., Xu, C., Shi, H., Jiang, X., Tang, W., Wu, X., Chen, M., Li, H., Zhang, X., & Cheng, Q. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02481-7 · Cited by 32
Bone phenotypes in rheumatology – there is more to bone than just bone
Thudium, C. S., Nielsen, S. H., Sardar, S., Mobasheri, A., van Spil, W. E., Lories, R. J. U., Henriksen, K., Bay‐Jensen, A., & Karsdal, M. A. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03804-2 · Cited by 33
Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation
Ladang, A., Rauch, F., DELVIN, E. E., & Cavalier, E. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-00964-2 · Cited by 34
Moringa oleifera leaf attenuate osteoporosis in ovariectomized rats by modulating gut microbiota composition and MAPK signaling pathway
Hu, X., Yang, X.-Y., Lian, J., Chen, Y., Zheng, C., Tao, S., Liu, N., Liu, Q., & Jiang, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114434 · Cited by 35
Self‐Mineralizing Dnazyme Hydrogel as a Multifaceted Bone Microenvironment Amendment for Promoting Osteogenesis in Osteoporosis
Wu, H., Huang, S., Zhu, Y., Li, J., Pang, X., Tang, Y., Li, S., Ji, P., Ding, S., Cheng, W., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202212669 · Cited by 30
The Role of Oxidative Stress in Multiple Exercise-Regulated Bone Homeostasis
Gao, H., Zhao, Y., Zhao, L., Wang, Z., Yan, K., Gao, B., & Zhang, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0223 · Cited by 34
Curcumin Ameliorated Glucocorticoid-Induced Osteoporosis While Modulating the Gut Microbiota and Serum Metabolome
Li, S., Zhang, Y., Ding, S., Chang, J., Liu, G., & Hu, S. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06689 · Cited by 30
Effects of recreational team handball on bone health, postural balance and body composition in inactive postmenopausal women — A randomised controlled trial
Pereira, R., Krustrup, P., Castagna, C., Coelho, E., Santos, R., Helge, E. W., Jørgensen, N. R., Magalhães, J., & Póvoas, S. C. A. (2021) · Bone · doi:10.1016/j.bone.2021.115847 · Cited by 30
Circular RNA_0062582 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via regulation of microRNA-145/CBFB axis
Li, F., Wu, H., Zou, G., Cang, D., & Shen, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1921553 · Cited by 30
Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
Curtis, E. M., Parsons, C. M., Maslin, K., D’Angelo, S., Moon, R. J., Crozier, S., Gossiel, F., Bishop, N. J., Kennedy, S., Papageorghiou, A. T., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab264 · Cited by 30
Self-citation
Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts
Wu, R., Lian, W., Chen, Y., Ko, J., Wang, S.-Y., Jahr, H., & Wang, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179476 · Cited by 30
Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?
Jiang, N., Liu, J., Guan, C., Ma, C., An, J., & Tang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955128 · Cited by 30
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis
Liu, H., Xiao, H., Lin, S., Zhou, H., Cheng, Y., Xie, B., & Xu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1372399 · Cited by 35
Zoledronate Sequential Therapy After Denosumab Discontinuation to Prevent Bone Mineral Density Reduction
Lee, C., Wang, C.-Y., Yen, H., Hung, C., Lai, C., Hu, M., Wang, T., Li, C., & Fu, S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.43899 · Cited by 29
Kindlin-2 deletion in osteoprogenitors causes severe chondrodysplasia and low-turnover osteopenia in mice
Wu, X., Qu, M., Gong, W., Zhou, C., Lai, Y., & Xiao, G. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2021.08.005 · Cited by 29
Guías de práctica clínica en la osteoporosis postmenopáusica, glucocorticoidea y del varón (actualización 2022)
Riancho, J., Peris, P., González-Macı́as, J., & Pérez-Castrillón, J.-L. (2022) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2022000100003 · Cited by 36
Early effects of ovariectomy on bone microstructure, bone turnover markers and mechanical properties in rats
Guo, X., Yu, X., Yao, Q., & Qin, J. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05265-1 · Cited by 28
Exercise improved bone health in aging mice: a role of SIRT1 in regulating autophagy and osteogenic differentiation of BMSCs
Zhu, C., Ding, H., Shi, L., Zhang, S., Tong, X., Huang, M., Liu, L., Guan, X., Zou, J., Yuan, Y. J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1156637 · Cited by 28
Biomarkers of Aging and Relevant Evaluation Techniques: A Comprehensive Review
Xue, T., Zhu, Z., Wang, L., Li, C., Sun, L., Wang, W., & Gong, W. (2023) · Aging and Disease · doi:10.14336/ad.2023.00808-1 · Cited by 37
Clinical Use of Bone Turnover Markers
Bauer, D. C. (2019) · JAMA · doi:10.1001/jama.2019.9372 · Cited by 30
Mouse mutant phenotyping at scale reveals novel genes controlling bone mineral density
Swan, A., Schütt, C., Rozman, J., Moreno, M. D. M. M., Brandmaier, S., Simon, M., Leuchtenberger, S., Griffiths, M. N. D., Brommage, R., Keskivali-Bond, P., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009190 · Cited by 27
Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study
Qin, X., Niu, Z.-C., Han, X.-L., Yang, Y. S., Wei, Q., Gao, X., An, R., Han, L., Yang, W., Chai, L., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113815 · Cited by 28
Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
Hong, P., Liu, R., Rai, S., Liu, J., Zhou, Y., Zheng, Y., & Li, J. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03595-x · Cited by 28
Rare adverse effects of bisphosphonate therapy
Ilyas, Z., & Camacho, P. M. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000501 · Cited by 28
Patient-specific risk factors for adverse outcomes following geriatric proximal femur fractures
Becker, N., Hafner, T., Pishnamaz, M., Hildebrand, F., & Kobbe, P. (2022) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-022-01953-8 · Cited by 27

Authors: Eastell, R., & Szulc, P.
Affiliations: University of Sheffield (GB)
Corresponding author: Eastell, Richard
ORCID: Eastell, Richard
Venue: The Lancet Diabetes & Endocrinology
Publisher: Elsevier BV
Published: 2017-11
Volume: 5
Issue: 11
Pages: 908-923
ISSN: 2213-8587 (ISSN-L)
DOI: 10.1016/s2213-8587(17)30184-5
OpenAlex: W2733907025
Cited by: 594
References: 168
Citations by year: 2026: 62 · 2025: 94 · 2024: 89 · 2023: 82 · 2022: 92 · 2021: 75 · 2020: 47 · 2019: 32 · 2018: 18 · 2017: 3
FWCI: 4.97
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Diabetes & Endocrinology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute for Health and Care Research (NF-SI-0513-10073)
Medical Research Council (MR/K006312/1, MR/P020941/1)
Topics: Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Health Sciences › Medicine › Oncology › Bone health and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords: bone turnover markers, postmenopausal osteoporosis, bone resorption, bone formation, P1NP, C-terminal telopeptide of type I collagen, secondary osteoporosis, fracture risk prediction
MeSH terms: Diphosphonates, Humans, Biomarkers, Bone Density, Osteoporosis, Postmenopausal, Bone Remodeling, Fracture Healing, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Use of bone turnover markers in postmenopausal osteoporosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks